Biomedical Engineering Reference
In-Depth Information
894. Sundaram M, Yao SY, Ng AM, Griffiths M, Cass CE, Baldwin Sa, Young JD. 1998.
Chimaeric constructs between human and rat equilibrative nucleoside transporters
(hENT1 and rENT1) reveal hENT1 structural domains interacting with coronary
vasoactive drugs. J Biol Chem 273: 21519-21525.
895. Smith PG, Thomas HD, Barlow HC, Griffin RJ, Golding BT, Calvert AH, Newell DR,
Curtin NJ. 2001. In vitro and in vivo properties of novel nucleoside transport inhibitors
with improved pharmacological properties that potentiate antifolate activity. Clin Cancer
Res 7: 2105-2113.
896. Huang M, Wang Y, Collins M, Gu JJ, Mitchell BS, Graves LM. 2002. Inhibition of
nucleoside transport by p38 MAPK inhibitors. J Biol Chem 277: 28364-28367.
897. Huang M, Wang Y, Cogut SB, Mitchell BS, Graves LM. 2003. Inhibition of nucleoside
transport by protein kinase inhibitors. J Pharmacol Exp Ther 304: 753-760.
898. Huang M, Wang Y, Mitchell BS, Graves LM. 2004. Regulation of equilibrative
nucleoside uptake by protein kinase inhibitors. Nucleosides Nucleotides Nucleic Acids
23: 1445-1450.
899. Leung GP, Man RY, Tse CM. 2005. Effect of thiazolidinediones on equilibrative nucleo-
side transporter-1 in human aortic smooth muscle cells. Biochem Pharmacol 70: 355-62.
900. Choi DS, Cascini MG, Mailliard W, Young H, Paredes P, McMahon T, Diamond I, Bonci
A, Messing RO. 2004. The type 1 equilibrative nucleoside transporter regulates ethanol
intoxication and preference. Nat Neurosci 7: 855-861.
901. Nagy LE, Diamond I, Casso DJ, Franklin C, Gordon AS. 1990. Ethanol increases
extracellular adenosine by inhibiting adenosine uptake via the nucleoside transporter.
J Biol Chem 265: 1946-1951.
902. Gupte A, Buolamwini JK, Yadav V, Chu CK, Naguib FN, el Kouni MH. 2005.
6-Benzylthioinosine analogues: promising anti-toxoplasmic agents as inhibitors of the
mammalian nucleoside transporter ENT1 (es). Biochem Pharmacol 71: 69-73.
903. Valdes R, Casado FJ, Pastor-Anglada M. 2002. Cell-cycle-dependent regulation of CNT1,
a concentrative nucleoside transporter involved in the uptake of cell-cycle-dependent
nucleoside-derived anticancer drugs. Biochem Biophys Res Commun 296: 575-579.
904. Pressacco J, Wiley JS, Jamieson GP, Erlichman C, Hedley DW. 1995. Modulation of
the equilibrative nucleoside transporter by inhibitors of DNA-synthesis. Br J Cancer 72:
939-942.
905. Pastor-Anglada M, Casado FJ, Valdes R, Mata J, Garcia-Manteiga J, Molina M. 2001.
Complex regulation of nucleoside transporter expression in epithelial and immune
system cells. Mol Membr Biol 18: 81-85.
906. Valdes R, Ortega MA, Casado FJ, Felipe A, Gil A, Sanchez-Pozo A, Pastor-Anglada M.
2000. Nutritional regulation of nucleoside transporter expression in rat small intestine.
Gastroenterology 119: 1623-1630.
907. Felipe A, Valdes R, Santo B, Lloberas J, Casado J, Pastor-Anglada M. 1998. Na
+
-
dependent nucleoside transport in liver: two different isoforms from the same gene
family are expressed in liver cells. Biochem J 330: 997-1001.
908. Coe I, Zhang Y, McKenzie T, Naydenova Z. 2002. PKC regulation of the human
equilibrative nucleoside transporter, hENT1. FEBS Lett 517: 201-205.
909. Soler C, Felipe A, Mata JF, Casado FJ, Celada A, Pastor-Anglada M. 1998. Regulation
of nucleoside transport by lipopolysaccharide, phorbol esters, and tumor necrosis
factor-alpha in human B-lymphocytes. J Biol Chem 273: 26939-26945.
Search WWH ::
Custom Search